CYBN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation...

Stats
Today's Volume	3.44M
Average Volume	5.44M
Market Cap	269.69M
EPS	$0 ( 2024-02-13 )
Next earnings date	( $-0.0300 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.610
ATR14	$0.00100 (0.28%)

Volume Correlation

Long: 0.43 (neutral)

Short: 0.97 (very strong)

Signal:(78.791) Expect same movement, but be aware

Cybin Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cybin Inc. Correlation - Currency/Commodity

0.00
( neutral )

Cybin Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-251 000 (0.00 %)
EPS:	$-0.220

Q3	2023
Revenue:	$0
Gross Profit:	$-142 000 (0.00 %)
EPS:	$-0.0909

Q2	2023
Revenue:	$0
Gross Profit:	$-71 000.00 (0.00 %)
EPS:	$-0.0507

Q1	2023
Revenue:	$0
Gross Profit:	$-69 000.00 (0.00 %)
EPS:	$-0.0600

Financial Reports:

No articles found.

Cybin Inc.